EPA RMP Citations @ Pharmaceutical Facility (Aqueous NH3 & Methylamine Gas; $190K and lowering inventories)
Respondent is the owner and/or operator of a pharmaceutical manufacturing facility which uses ammonia (conc. 20% or greater) ("aqueous ammonia") and methylamine gas in two (2) processes for the manufacture of pharmaceuticals. EPA conducted an inspection of the Facility on or about January 31 , 2014 to assess compliance with 40 C.F.R. Part 68. Respondent subsequently sent a letter dated October 19, 2015 to EPA which provided updated information about the quantities of aqueous ammonia and methylamine at the facility from 2012-2015. Respondent did not submit an RMP to EPA. |
Partner Organizations I am proud to announce that The Chlorine Institute and SAFTENG have extended our"Partners in Safety" agreement for another year (2024) CI Members, send me an e-mail to request your FREE SAFTENG membership
Member Associations
|
